[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Pradaxa Market Report 2017

October 2017 | 96 pages | ID: U3F169EC769PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Pradaxa market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Pradaxa in these regions, from 2012 to 2022 (forecast).
United States Pradaxa market competition by top manufacturers/players, with Pradaxa sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Bayer Healthcare
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • Aspen Holdings
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Type 1
  • Type 2
  • Type 3
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pradaxa for each application, including
  • Medical uses
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Pradaxa Market Report 2017

1 PRADAXA OVERVIEW

1.1 Product Overview and Scope of Pradaxa
1.2 Classification of Pradaxa by Product Category
  1.2.1 United States Pradaxa Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pradaxa Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Type
  1.2.4 Type
  1.2.5 Type
1.3 United States Pradaxa Market by Application/End Users
  1.3.1 United States Pradaxa Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Medical uses
  1.3.3 Others
1.4 United States Pradaxa Market by Region
  1.4.1 United States Pradaxa Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pradaxa Status and Prospect (2012-2022)
  1.4.3 Southwest Pradaxa Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pradaxa Status and Prospect (2012-2022)
  1.4.5 New England Pradaxa Status and Prospect (2012-2022)
  1.4.6 The South Pradaxa Status and Prospect (2012-2022)
  1.4.7 The Midwest Pradaxa Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pradaxa (2012-2022)
  1.5.1 United States Pradaxa Sales and Growth Rate (2012-2022)
  1.5.2 United States Pradaxa Revenue and Growth Rate (2012-2022)

2 UNITED STATES PRADAXA MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pradaxa Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pradaxa Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pradaxa Average Price by Players/Suppliers (2012-2017)
2.4 United States Pradaxa Market Competitive Situation and Trends
  2.4.1 United States Pradaxa Market Concentration Rate
  2.4.2 United States Pradaxa Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pradaxa Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PRADAXA SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pradaxa Sales and Market Share by Region (2012-2017)
3.2 United States Pradaxa Revenue and Market Share by Region (2012-2017)
3.3 United States Pradaxa Price by Region (2012-2017)

4 UNITED STATES PRADAXA SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pradaxa Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pradaxa Revenue and Market Share by Type (2012-2017)
4.3 United States Pradaxa Price by Type (2012-2017)
4.4 United States Pradaxa Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PRADAXA SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pradaxa Sales and Market Share by Application (2012-2017)
5.2 United States Pradaxa Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PRADAXA PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pradaxa Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer Healthcare
  6.2.2 Pradaxa Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Healthcare Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
  6.3.2 Pradaxa Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
  6.4.2 Pradaxa Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aspen Holdings
  6.5.2 Pradaxa Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aspen Holdings Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb Company
  6.6.2 Pradaxa Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb Company Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceutical Industries
  6.7.2 Pradaxa Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Teva Pharmaceutical Industries Pradaxa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 PRADAXA MANUFACTURING COST ANALYSIS

7.1 Pradaxa Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pradaxa

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pradaxa Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pradaxa Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PRADAXA MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pradaxa Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pradaxa Sales Volume Forecast by Type (2017-2022)
11.3 United States Pradaxa Sales Volume Forecast by Application (2017-2022)
11.4 United States Pradaxa Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Pradaxa
Figure United States Pradaxa Market Size (K Units) by Type (2012-2022)
Figure United States Pradaxa Sales Volume Market Share by Type (Product Category) in 2016
Figure Type 1 Product Picture
Figure Type 2 Product Picture
Figure Type 3 Product Picture
Figure United States Pradaxa Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Pradaxa by Application in 2016
Figure Medical uses Examples
Table Key Downstream Customer in Medical uses
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Pradaxa Market Size (Million USD) by Region (2012-2022)
Figure The West Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pradaxa Sales (K Units) and Growth Rate (2012-2022)
Figure United States Pradaxa Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pradaxa Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Pradaxa Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Pradaxa Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pradaxa Sales Share by Players/Suppliers
Figure 2017 United States Pradaxa Sales Share by Players/Suppliers
Figure United States Pradaxa Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pradaxa Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pradaxa Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pradaxa Revenue Share by Players/Suppliers
Figure 2017 United States Pradaxa Revenue Share by Players/Suppliers
Table United States Market Pradaxa Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Pradaxa Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Pradaxa Market Share of Top 3 Players/Suppliers
Figure United States Pradaxa Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pradaxa Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pradaxa Product Category
Table United States Pradaxa Sales (K Units) by Region (2012-2017)
Table United States Pradaxa Sales Share by Region (2012-2017)
Figure United States Pradaxa Sales Share by Region (2012-2017)
Figure United States Pradaxa Sales Market Share by Region in 2016
Table United States Pradaxa Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pradaxa Revenue Share by Region (2012-2017)
Figure United States Pradaxa Revenue Market Share by Region (2012-2017)
Figure United States Pradaxa Revenue Market Share by Region in 2016
Table United States Pradaxa Price (USD/Unit) by Region (2012-2017)
Table United States Pradaxa Sales (K Units) by Type (2012-2017)
Table United States Pradaxa Sales Share by Type (2012-2017)
Figure United States Pradaxa Sales Share by Type (2012-2017)
Figure United States Pradaxa Sales Market Share by Type in 2016
Table United States Pradaxa Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pradaxa Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pradaxa by Type (2012-2017)
Figure Revenue Market Share of Pradaxa by Type in 2016
Table United States Pradaxa Price (USD/Unit) by Types (2012-2017)
Figure United States Pradaxa Sales Growth Rate by Type (2012-2017)
Table United States Pradaxa Sales (K Units) by Application (2012-2017)
Table United States Pradaxa Sales Market Share by Application (2012-2017)
Figure United States Pradaxa Sales Market Share by Application (2012-2017)
Figure United States Pradaxa Sales Market Share by Application in 2016
Table United States Pradaxa Sales Growth Rate by Application (2012-2017)
Figure United States Pradaxa Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Pradaxa Sales Growth Rate (2012-2017)
Figure Pfizer Pradaxa Sales Market Share in United States (2012-2017)
Figure Pfizer Pradaxa Revenue Market Share in United States (2012-2017)
Table Bayer Healthcare Basic Information List
Table Bayer Healthcare Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Healthcare Pradaxa Sales Growth Rate (2012-2017)
Figure Bayer Healthcare Pradaxa Sales Market Share in United States (2012-2017)
Figure Bayer Healthcare Pradaxa Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pradaxa Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Pradaxa Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Pradaxa Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Pradaxa Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Pradaxa Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Pradaxa Revenue Market Share in United States (2012-2017)
Table Aspen Holdings Basic Information List
Table Aspen Holdings Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aspen Holdings Pradaxa Sales Growth Rate (2012-2017)
Figure Aspen Holdings Pradaxa Sales Market Share in United States (2012-2017)
Figure Aspen Holdings Pradaxa Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Pradaxa Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Pradaxa Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Pradaxa Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Pradaxa Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Pradaxa Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Pradaxa Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Pradaxa Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pradaxa
Figure Manufacturing Process Analysis of Pradaxa
Figure Pradaxa Industrial Chain Analysis
Table Raw Materials Sources of Pradaxa Major Players/Suppliers in 2016
Table Major Buyers of Pradaxa
Table Distributors/Traders List
Figure United States Pradaxa Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pradaxa Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pradaxa Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Pradaxa Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pradaxa Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pradaxa Sales Volume (K Units) Forecast by Type in 2022
Table United States Pradaxa Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pradaxa Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pradaxa Sales Volume (K Units) Forecast by Application in 2022
Table United States Pradaxa Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Pradaxa Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pradaxa Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pradaxa Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications